Regeneron Pharma REG has outperformed the market by 21.24% on an annualized basis over the past 15 years and has produced a compound annual return of 27.82%. Regeneron Pharmaceuticals currently has a market cap of $81.63 billion.
Purchase of $1000 in REGN: If an investor bought $1000 worth of REGN stock 15 years ago, it would be worth it $39,727.00 today based on a price of $748.85 for REGN at the time of writing.
Regeneron Pharmaceuticals’ performance over the past 15 years
Finally – what is all this? The most important takeaway to take from this article is how much of a difference compound returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Source story
